Friday 6 November 2026 Export VRDN’s income statement to Excel — free account

Viridian Therapeutics, Inc.

Viridian Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $70.8 million, up 23,359.9% from fiscal 2024.

Revenue: −63.5%
EPS: −5.00%
Free cash flow: −9.92%
Total debt: +1,064.9%

Quarter to September 2026, against a year earlier

Insider buying

28.82 0.27 +0.95%

Follow VRDN

Alert me

Market cap: $3.2B
P/E: 0.0×
Fwd P/E: −6.2×
Dividend yield: —
F-score: 3/9
Altman Z: 6.69
Beneish M: n/a
Dividend safety: n/a

Overview

	Sep '26 From the 10-Q filed 4 Nov	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	0.00%	(86.93%)	(78.43%)	(63.87%)	+8 more TTM periods Free account
Piotroski F-Score Full definition →	—	4	2	3
ROA Full definition →	(56.49%)	(46.08%)	(49.74%)	(41.73%)
ROIC Full definition →	0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →	(47.95%)	(37.93%)	(49.12%)	(41.54%)
Average Days of Receivables Full definition →	0.00	384.87	0.00	0.00
Free Cash Flow per Share Full definition →	0.00	(3.11)	(2.97)	(3.26)
Free Cash Flow Full definition →	(343.44)	(335.04)	(303.82)	(276.89)
Capital Expenditures Full definition →	(1.94)	(1.70)	(0.43)	(0.49)
Other line items
Cash ROIC Full definition →	(22.36%)	(17.77%)	(20.97%)	(16.81%)
Accounts Receivable Turnover Full definition →	0.00	1.89	0.00	0.00
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	1,172.63%	456.47%	479.04%	478.38%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	213.21%	164.83%	134.53%
Share Based Compensation of Revenue Full definition →	226.52%	75.38%	66.94%	62.53%
Interest Coverage Full definition →	—	(25.89)	(49.07)	(73.44)
Operating CF/Net income Full definition →	0.75	0.86	0.84	0.81
Depreciation/Fixed assets Full definition →	(1.99)	(2.07)	(5.16)	(5.13)
Capex/Depreciation Full definition →	0.33	0.30	0.07	0.08
Revenue per Share Full definition →	0.00	0.66	0.69	0.84
Operating CF per Share Full definition →	0.00	(3.09)	(2.97)	(3.26)
Capex per Share Full definition →	0.00	(0.02)	0.00	(0.01)
Capex to Sales Full definition →	0.07	0.02	0.01	0.01

Show all line items

Columns are period end dates · fundamentals updated 4 Nov 2026

Stockrow Weekly